Biodegradable Synthetic Organelles Demonstrate ROS Shielding in Human-Complex-I-Deficient Fibroblasts
Author(s) -
Lisanne M.P.E. van Oppen,
Loai K. E. A. Abdelmohsen,
Sjenet E. van Emstde Vries,
Pascal L. W. Welzen,
Daniela A. Wilson,
Jan Smeitink,
Werner J.H. Koopman,
Roland Brock,
Peter H.G.M. Willems,
David Williams,
Jan C. M. van Hest
Publication year - 2018
Publication title -
acs central science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.893
H-Index - 76
eISSN - 2374-7951
pISSN - 2374-7943
DOI - 10.1021/acscentsci.8b00336
Subject(s) - polymersome , nanoreactor , ethylene glycol , chemistry , nanotechnology , artificial cell , biophysics , materials science , membrane , biochemistry , nanoparticle , copolymer , biology , organic chemistry , amphiphile , polymer
Biodegradable, semipermeable nanoreactors that are capable of undergoing cellular integration and, subsequently, function as synthetic organelles represent an exciting therapeutic technology. Polymersomal nanoreactors have been investigated as a suitable candidate for the engineering of such a system, with the chemical versatility and structural robustness required for such a demanding application. Although steps have been taken to demonstrate this capacity, there has yet to be a system presented with biochemically robust data showing therapeutic efficacy in primary human cells. The reason for this shortfall is the absence of essential criteria of the polymersomes tested so far; biodegradability, intrinsic semipermeability, and a biomedically relevant setting. Herein, we present enzyme-loaded, biodegradable poly(ethylene glycol)-block-poly(caprolactone-gradient-trimethylene carbonate) (PEG–PCLgTMC) polymersomal nanoreactors, readily fabricated using the biocompatible direct hydration methodology. Physical...
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom